Weight Loss

RetailDavid Protein CEO says ‘diet trends are over’ because of GLP-1s: ‘What’s next is really hard to predict’
By Sasha RogelbergJune 28, 2026

By Christina SnyderDecember 18, 2025

By Christina SnyderDecember 18, 2025

By Christina SnyderDecember 12, 2025

HealthFDA warns Hims & Hers and other weight loss drugmakers to remove ‘false and misleading’ advertising
By The Associated PressSeptember 16, 2025

NewslettersExclusive: The founders of SoulCycle built a startup for relationships, then pivoted to GLP-1 support groups. Now its assets are being acquired by WeightWatchers
By Emma HinchliffeAugust 7, 2025

By Michelle Amponsah and BloombergJune 20, 2025

By Beth GreenfieldJune 5, 2025

By Jonel Aleccia and The Associated PressMay 12, 2025

HealthCurrency hedging and new U.S. factories: Novo Nordisk CFO thinks Wegovy maker can outmaneuver global trade wars
By Ryan HoggMay 9, 2025

FinanceWeightWatchers files for bankruptcy as it struggles for a place in a weight loss world dominated by Ozempic and Wegovy
By The Associated PressMay 7, 2025

CommentaryThe crisis over GLP-1 out-of-pocket costs deepens—it’s time for health-care leaders to step up
By Wendy BarnesMarch 4, 2025
Most Popular





